VeeralShethMDMBA, FACS

Ophthalmology • Oak Forest, IL

Glaucoma Related, Retinal Disease, Uveitis

Physician and Surgeon Clinical Assistant Professor, University of Illinois at Chicago

Join to view full profile

Dr. Sheth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sheth's full profile

Already have an account?

Office
6320 159th St
Ste A
Oak Forest, IL 60452
Phone+1 708-687-2222

Fax+1 708-687-3829

Education & Training

Northwestern University (Kellogg)MBA, 2012 - 2014
University of ChicagoFellowship, Surgical Retina and Vitreous, 2010
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 2004 - 2008
West Suburban Medical CenterInternship, Transitional Year, 2004 - 2005
University of Illinois College of MedicineClass of 2004

Certifications & Licensure

IL State Medical License 2008 - 2026
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Fellow (FACS) American College of Surgeons
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD Start of enrollment: 2005 Jun 01
Completed
Phase 1
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) Start of enrollment: 2006 Apr 01
Completed
Phase 2
Age-Related Eye Disease Study 2 (AREDS2) Start of enrollment: 2006 Sep 01
Completed
Phase 3
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
COMPLETED
PHASE2
Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Completed
Join now to see all

Publications & Presentations

PubMed

Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration.
David A Eichenbaum, Nancy Holekamp, Arshad M Khanani, Dante Pieramici, Vrinda Hershberger
American Journal of Ophthalmology. 2025-03-13
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial.
Arshad M Khanani, Peter A Campochiaro, Jordan M Graff, Dennis M Marcus, Daniel Miller
JAMA Ophthalmology. 2025-03-06
2 citations
Retinal fluid quantification using a novel deep learning algorithm in patients treated with faricimab in the TRUCKEE study.
Aamir A Aziz, Arshad M Khanani, Hannah Khan, Eileen Lauer, Ibrahim Khanani
Eye. 2024-12-11

Books/Book Chapters

The Massachusetts Eye and Ear Infirmary Review Manual for Ophthalmology
Sheth V, Marcet M, Chiranand P, Bhatt HK, Lamkin JC, Jager RDLippincott Williams & WilkinsEdition 4,2012

Press Mentions

Oculis Accelerates Enrollment for Phase 3 DIAMOND Trials of OCS-01 Eye Drops in DMEOctober 21st, 2024
EyeSouth Partners Expands Clinical Research Division - Healthcare and Medical News for Atlanta PhysiciansJuly 9th, 2024
Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 ConferenceFebruary 6th, 2024

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow
American College of Surgeons - ACS
Member

Other Languages

Spanish, Gujarati